A survey led by researchers from the Center for Quantitative Health at Massachusetts General Hospital and Harvard Medical School has analyzed the association between self-reported social media use and irritability among US adults. Frequent social media use, especially among active posters, was correlated with higher levels of irritability.
Existing studies on social media and mental health predominantly focus on depressive symptoms, with limited attention to other negative emotions such as irritability. Irritability, defined as a tendency toward anger and frustration, has been linked to functional impairments, poorer mental health outcomes, and suicidal behaviors.
While prior research has established connections between social media use and depressive symptoms, the extent to which social media engagement is associated with irritability or its influence on depression and anxiety has remained uncertain.
In the study, “Irritability and Social Media Use in US Adults,” published in JAMA Network Open, the research team used data from two waves of the COVID States Project, a nationwide nonprobability web-based survey conducted between November 2, 2023, and January 8, 2024, which included questions about social media use and irritability.
Researchers evaluated the relationship between social media use and irritability by analyzing responses from 42,597 participants using multiple linear regression models.
The survey collected sociodemographic data, self-reported social media usage, and measures of irritability. Participants completed the Brief Irritability Test (BITe), which consists of five statements evaluating irritability symptoms over the previous two weeks. Scores range from 5 to 30, with higher scores indicating higher levels of irritability. The analysis also included depression and anxiety metrics to account for overlapping psychological symptoms.
Social media use was categorized based on frequency: never, less than once per week, once per week, several times per week, once per day, several times per day, or most of the day. Platforms analyzed included Facebook, Instagram, TikTok, and Twitter/X. Frequency of active posting, political engagement, and political affiliation were also examined to identify potential confounding factors.
Participants had a mean age of 46 years, with 58.5% identifying as women, 40.4% as men, and 1.1% as nonbinary. Among respondents, 78.2% reported daily use of at least one social media platform. Frequent social media use correlated with higher irritability scores, even after adjusting for anxiety and depression.
For example, participants using social media most of the day scored 3.37 points higher on the BITe in unadjusted models. After adjusting for anxiety and depression, the increase remained significant at 1.55 points.
Platform-specific analyses revealed a dose-response relationship between posting frequency and irritability. Posting multiple times per day was associated with the highest irritability levels across all platforms, with TikTok users showing the largest increase (1.94 points; 95% CI, 1.57-2.32 points).
Political engagement variables, such as frequent political posting or consuming political news, were associated with increased irritability. Political engagement did not diminish the observed relationship between social media use and irritability, though following political news “not very closely” was associated with a slight decrease.
High social media engagement levels, particularly frequent posting, were associated with greater irritability in US adults. While the study could not establish direct causation, findings suggest a potential feedback loop relationship, where irritability may both influence a desire to engage and increase irritation from social media use.
Further research is needed to explore the mechanisms driving this association and its implications for public health, as well as possible intervention strategies.
More information: Roy H. Perlis et al, Irritability and Social Media Use in US Adults, JAMA Network Open (2025). DOI: 10.1001/jamanetworkopen.2024.52807
News
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
Scientists Discover the Brain Protein That Helps Alzheimer’s Spread Through the Brain
Scientists have identified a brain protein that may help Alzheimer’s spread, revealing a potential new target for slowing the disease’s progression. Alzheimer’s disease is closely linked to the accumulation of a toxic form of the protein [...]
How Immune Dysregulation Contributes to Psychiatric Disorders
Introduction Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, [...]
Electrostatic Discharge Boosts Triboelectric Nanogenerator Current and Enables DC Output
Controlled electrical discharges could enable triboelectric nanogenerators to achieve higher peak currents, extending nano-enabled energy harvesting into chemical processing and self-powered sensing. Paper: Electrostatic discharge as a breakthrough strategy for triboelectric nanogenerators. A new review [...]
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
Nanozyme Aptasensors Show Promise for Faster Food, Health, and Environmental Testing
By pairing robust artificial enzymes with highly selective aptamers, nanozyme aptasensors could help detect disease biomarkers, pathogens, and contaminants faster, but the review shows that real-world deployment still depends on overcoming matrix interference, biofouling, [...]
Paralyzed Man Feels Sensation Again With Brain Stimulation Device
Aneuroprosthetic system has allowed a man with paralysis to grasp and lift objects and feel touch again. The device helped 42-year-old Keith Thomas of Massapequa, New York, who was paralyzed from the chest down [...]
